Published in Dig Dis Sci on September 21, 2010
Liver biopsy. N Engl J Med (2001) 9.91
Liver biopsy. Hepatology (2009) 7.61
Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med (1993) 3.83
Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut (1999) 3.10
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol (2010) 2.96
Cost-effectiveness of ultrasound-guided liver biopsy. Hepatology (1998) 2.06
Outpatient liver biopsy: how safe is it? Ann Intern Med (1993) 1.90
Patient time requirements for screening colonoscopy. Am J Gastroenterol (2007) 1.74
Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland. Dig Dis Sci (1993) 1.52
The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology (1996) 1.48
Prospective analysis of complications 30 days after outpatient colonoscopy. Gastrointest Endosc (1999) 1.47
Statement on outpatient percutaneous liver biopsy. Dig Dis Sci (1989) 1.45
Ultrasound-guided liver biopsy for parenchymal liver disease: an economic analysis. Dig Dis Sci (1998) 1.41
Incidence of ultrasound-detected intrahepatic hematomas due to Tru-cut needle liver biopsy. Dig Dis Sci (1991) 1.35
Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol (2008) 1.13
Percutaneous liver biopsy in clinical practice. Liver Int (2007) 1.06
A survey of current liver biopsy practice patterns. J Clin Gastroenterol (2002) 1.03
Short recovery time after percutaneous liver biopsy: should we change our current practices? Clin Gastroenterol Hepatol (2005) 1.01
Predictors of pain medication use after percutaneous liver biopsy. Dig Dis Sci (2002) 0.92
How often does ultrasound marking change the liver biopsy site? Am J Gastroenterol (1999) 0.92
Routine ultrasound-guided liver biopsy: a time whose idea has come? J Clin Gastroenterol (2005) 0.92
Ultrasound-guided liver biopsy in real life: comparison of same-day prebiopsy versus real-time ultrasound approach. J Gastroenterol Hepatol (2007) 0.89
Percutaneous liver biopsy: retrospective study over 15 years comparing 287 inpatients with 428 outpatients. J Gastroenterol Hepatol (2009) 0.89
Percutaneous liver biopsy using an ultrasound-guided subcostal route. Dig Dis Sci (2001) 0.89
Percutaneous liver biopsy: what is the current approach? Results of a questionnaire survey. Dig Dis Sci (2001) 0.85
Safety and efficacy of sonographic-guided random real-time core needle biopsy of the liver. J Clin Ultrasound (2009) 0.85
Ultrasound-guided percutaneous liver biopsy: indications, risks, and technique. Surg Technol Int (2003) 0.84
Complications after percutaneous liver biopsy in diffuse hepatopathies. Rom J Gastroenterol (2005) 0.84
Post-procedure surveillance in liver biopsy: how long is long enough? N Z Med J (2008) 0.81
The efficacy of liver biopsy under ultrasonographic guidance on an outpatient basis. Eur J Ultrasound (2002) 0.81
Same day endoscopy and percutaneous liver biopsy: safety and cost-effectiveness. Dig Dis Sci (2008) 0.77
Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time? Dig Dis Sci (2007) 1.83
Causality assessment of drug-induced hepatotoxicity: promises and pitfalls. Clin Liver Dis (2007) 1.32
Hepatic decompensation likely attributable to simeprevir in patients with advanced cirrhosis. Dig Dis Sci (2014) 1.27
High-resolution chromoendoscopy for classifying colonic polyps: a multicenter study. Gastrointest Endosc (2002) 1.14
The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated. Gastrointest Endosc (2004) 1.11
Oncologists and hepatitis B: a survey to determine current level of awareness and practice of antiviral prophylaxis to prevent reactivation. Chemotherapy (2008) 1.07
Hepatic findings in long-term clinical trials of ximelagatran. Drug Saf (2005) 1.05
Drug-induced liver injury: a summary of recent advances. Expert Opin Drug Metab Toxicol (2011) 1.05
Hepatotoxicity of agents used in the management of inflammatory bowel disease. Dig Dis (2010) 1.00
Pancreatic tuberculosis diagnosed with endoscopic ultrasound guided fine needle aspiration. JOP (2005) 0.99
Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy. Arthritis Care Res (Hoboken) (2010) 0.99
Drug-induced liver injury in 2007. Curr Opin Gastroenterol (2008) 0.96
Drug- and chemical-induced cholestasis. Clin Liver Dis (2004) 0.93
Drug-induced liver injury: what was new in 2008? Expert Opin Drug Metab Toxicol (2009) 0.92
Predicting and preventing acute drug-induced liver injury: what's new in 2010? Expert Opin Drug Metab Toxicol (2010) 0.91
Constipation heralding neuroborreliosis: an atypical tale of 2 patients. Arch Neurol (2005) 0.90
Gone (from the Physicians' desk reference) but not forgotten: propylthiouracil-associated hepatic failure: a call for liver test monitoring. J Natl Med Assoc (2010) 0.90
Drug-induced liver disease in 2006. Curr Opin Gastroenterol (2007) 0.87
Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic. J Natl Med Assoc (2005) 0.87
Drug-induced liver disease 2004. Curr Opin Gastroenterol (2005) 0.84
Sumatriptan-associated ischemic colitis: case report and review of the literature and FAERS. Drug Saf (2014) 0.81
Latest advances in predicting DILI in human subjects: focus on biomarkers. Expert Opin Drug Metab Toxicol (2012) 0.81
Drug-induced liver disease in 2003. Curr Opin Gastroenterol (2004) 0.80
Dermatologists' awareness of and screening practices for hepatitis B virus infection before initiating tumor necrosis factor-α inhibitor therapy. South Med J (2011) 0.80
Hepatotoxicity of antibiotics: a review and update for the clinician. Clin Liver Dis (2013) 0.79
Drug-induced liver injury in the elderly. Curr Gastroenterol Rep (2013) 0.79
Drug-induced liver injury: what was new in 2013? Expert Opin Drug Metab Toxicol (2014) 0.78
Liver safety assessment: required data elements and best practices for data collection and standardization in clinical trials. Drug Saf (2014) 0.78
Fatal varicella-zoster hepatitis presenting with severe abdominal pain: a case report and review of the literature. Dig Dis Sci (2006) 0.77
Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection. Ann Pharmacother (2007) 0.76
Diagnosis: Liver biopsy differentiates DILI from autoimmune hepatitis. Nat Rev Gastroenterol Hepatol (2011) 0.76
Drug-induced liver disease. Curr Opin Gastroenterol (2003) 0.75
Did this drug cause my patient's hepatitis? Ann Intern Med (2003) 0.75
How the FDA handles GI drug safety. Am J Gastroenterol (2012) 0.75
Relationship between certain medications and cirrhosis. Am Fam Physician (2007) 0.75
Use of endoclips to obliterate a colonic arteriovenous malformation before cauterization. Gastrointest Endosc (2006) 0.75
Polypharmacy and comorbidity are associated with a lower early virologic response in hepatitis C patients treated with first generation protease inhibitor triple therapy: a preliminary analysis. Dig Dis Sci (2013) 0.75